Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Human Immunodeficiency Virus | Research

Regional disparity of HIV incidence and prevalence among men who have sex with men

Authors: D. N. Vergara-Ortega, H. López-Gatell, S. Bautista-Arredondo, A. Colchero, S. G. Sosa-Rubí, M. Morales-Vazquez, A. Herrera-Ortiz, M. Olamendi-Portugal, S. García-Cisneros, E. E. Sevilla-Reyes, M. Hernández-Avila, M. A. Sánchez-Alemán

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

HIV incidence can be estimated with cross-sectional studies using clinical, serological, and molecular data. Worldwide, HIV incidence data in only men who have sex with men (MSM) are scarce and principally focus on those with healthcare or under treatment. However, better estimates can be obtained through studies with national representativeness. The objective was to estimate the prevalence, incidence, and factors associated with acquiring HIV in a national sample of MSM who attend meeting places, considering geographical regions.

Methods

A nationally representative survey of MSM attending meeting places was performed in Mexico. Participants answered a questionnaire, and a dried blood spot (DBS) was collected. Samples were classified as recent infections using an algorithm with HIV status, antiretroviral therapy, and the result of BED-EIA assay. Parameters were analysed considering regions and demographic and sexual behaviour characteristics.

Results

The national HIV prevalence was 17.4% with regional differences; the highest prevalence (20.7%) was found in Mexico City, and the lowest prevalence was found in the West region (11.5%). The incidence was 9.4 per 100 p/y, with regional values from 6.2 to 13.2 for the Northeast and the Centre regions, respectively. Age, age at sexual debut, low wealth index, and rewarded sex were associated with HIV prevalence. Centre region, use of private clinics as health services, and having sex exclusively with men were associated with recent HIV infections.

Conclusions

The incidence and prevalence showed regional differences, suggesting a difference in the dynamics of HIV transmission; some regions have a greater case accumulation, and others have a greater rate of new infections. Understanding this dynamic will allow developing health programs focused on HIV prevention or treating people already living with HIV.
Literature
3.
go back to reference Gutiérrez JP, Sucilla-Pérez H, Conde-González CJ, Izazola JA, Romero-Martínez M, Hernández-Ávila M. Seroprevalencia de VIH en población mexicana de entre 15 y 49 años: resultados de la Ensanut 2012. Salud Publica Mex. 2014;56:323–32.CrossRef Gutiérrez JP, Sucilla-Pérez H, Conde-González CJ, Izazola JA, Romero-Martínez M, Hernández-Ávila M. Seroprevalencia de VIH en población mexicana de entre 15 y 49 años: resultados de la Ensanut 2012. Salud Publica Mex. 2014;56:323–32.CrossRef
4.
go back to reference Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa-Rubí SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS ONE. 2013;8(9):e72616.CrossRef Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa-Rubí SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS ONE. 2013;8(9):e72616.CrossRef
6.
go back to reference Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther. 2016;13:35.CrossRef Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther. 2016;13:35.CrossRef
7.
go back to reference National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of HIV/AIDS Prevention. Guidance on community viral load: a family of measures, definitions, and method for calculation. Division of HIV/AIDS Prevention. National Center for HIV/AIDS. 2011. https://stacks.cdc.gov/view/cdc/28147ER. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of HIV/AIDS Prevention. Guidance on community viral load: a family of measures, definitions, and method for calculation. Division of HIV/AIDS Prevention. National Center for HIV/AIDS. 2011. https://​stacks.​cdc.​gov/​view/​cdc/​28147ER.
8.
go back to reference Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13:459–64.CrossRef Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13:459–64.CrossRef
10.
go back to reference Colchero MA, Bautista-Arredondo S, Cortés-Ortiz MA, Romero-Martinez M, Salas J, Sosa-Rubí SG, et al. Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico. AIDS Lond Engl. 2016;30:293–300.CrossRef Colchero MA, Bautista-Arredondo S, Cortés-Ortiz MA, Romero-Martinez M, Salas J, Sosa-Rubí SG, et al. Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico. AIDS Lond Engl. 2016;30:293–300.CrossRef
11.
go back to reference Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22:511–8.CrossRef Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22:511–8.CrossRef
12.
go back to reference Karatzas-Delgado EF, Ruiz-González V, García-Cisneros S, Olamendi-Portugal ML, Herrera-Ortiz A, López-Gatell H, et al. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico. J Infect Public Health. 2020;13:509–13.CrossRef Karatzas-Delgado EF, Ruiz-González V, García-Cisneros S, Olamendi-Portugal ML, Herrera-Ortiz A, López-Gatell H, et al. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico. J Infect Public Health. 2020;13:509–13.CrossRef
13.
go back to reference Bravo-García E, Ortiz-Pérez H. Analysis of HIV/AIDS mortality in Mexico from 1990 to 2013: an assessment of the feasibility of millennium development goals by 2015. Gac Med Mex. 2016;152:819–30.PubMed Bravo-García E, Ortiz-Pérez H. Analysis of HIV/AIDS mortality in Mexico from 1990 to 2013: an assessment of the feasibility of millennium development goals by 2015. Gac Med Mex. 2016;152:819–30.PubMed
14.
go back to reference Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384:1005–70.CrossRef Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384:1005–70.CrossRef
15.
go back to reference Frank TD, Carter A, Jahagirdar D, Biehl MH, Douwes-Schultz D, Larson SL, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6:e831–59.CrossRef Frank TD, Carter A, Jahagirdar D, Biehl MH, Douwes-Schultz D, Larson SL, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6:e831–59.CrossRef
16.
go back to reference Luz PM, Veloso VG, Grinsztejn B. The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention. Curr Opin HIV AIDS. 2019;14:366–73.CrossRef Luz PM, Veloso VG, Grinsztejn B. The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention. Curr Opin HIV AIDS. 2019;14:366–73.CrossRef
17.
go back to reference van Griensven F, Mock PA, Benjarattanaporn P, Premsri N, Thienkrua W, Sabin K, et al. Estimating recent HIV incidence among young men who have sex with men: reinvigorating, validating and implementing Osmond’s algorithm for behavioral imputation. PLoS ONE. 2018;13:e0204793.CrossRef van Griensven F, Mock PA, Benjarattanaporn P, Premsri N, Thienkrua W, Sabin K, et al. Estimating recent HIV incidence among young men who have sex with men: reinvigorating, validating and implementing Osmond’s algorithm for behavioral imputation. PLoS ONE. 2018;13:e0204793.CrossRef
18.
go back to reference Lane T, Osmand T, Marr A, Struthers H, McIntyre JA, Shade SB. Brief report: high HIV incidence in a South African community of men who have sex with men: results from the mpumalanga Men’s study, 2012–2015. J Acquir Immune Defic Syndr. 2016;73:609–11.CrossRef Lane T, Osmand T, Marr A, Struthers H, McIntyre JA, Shade SB. Brief report: high HIV incidence in a South African community of men who have sex with men: results from the mpumalanga Men’s study, 2012–2015. J Acquir Immune Defic Syndr. 2016;73:609–11.CrossRef
19.
go back to reference Hallett TB. Estimating the HIV incidence rate: recent and future developments. Curr Opin HIV AIDS. 2011;6:102–7.CrossRef Hallett TB. Estimating the HIV incidence rate: recent and future developments. Curr Opin HIV AIDS. 2011;6:102–7.CrossRef
20.
go back to reference Marcus U, Voss L, Kollan C, Hamouda O. HIV incidence increasing in MSM in Germany: factors influencing infection dynamics. Euro Surveill. 2006;11:157–60.CrossRef Marcus U, Voss L, Kollan C, Hamouda O. HIV incidence increasing in MSM in Germany: factors influencing infection dynamics. Euro Surveill. 2006;11:157–60.CrossRef
22.
go back to reference Hernandez I, Reina-Ortiz M, Johnson A, Rosas C, Sharma V, Teran S, et al. Risk factors associated with HIV among men who have sex with men (MSM) in Ecuador. Am J Mens Health. 2017;11:1331–41.CrossRef Hernandez I, Reina-Ortiz M, Johnson A, Rosas C, Sharma V, Teran S, et al. Risk factors associated with HIV among men who have sex with men (MSM) in Ecuador. Am J Mens Health. 2017;11:1331–41.CrossRef
23.
go back to reference Brignol S, Kerr L, Amorim LD, Dourado I, Brignol S, Kerr L, et al. Factors associated with HIV infection among a respondent-driven sample of men who have sex with men in Salvador. Brazil Rev Bras Epidemiol. 2016;19:256–71.CrossRef Brignol S, Kerr L, Amorim LD, Dourado I, Brignol S, Kerr L, et al. Factors associated with HIV infection among a respondent-driven sample of men who have sex with men in Salvador. Brazil Rev Bras Epidemiol. 2016;19:256–71.CrossRef
24.
go back to reference Chamberlain N, Mena LA, Geter A, Crosby RA. Is sex with older male partners associated with higher sexual risk behavior among young black MSM? AIDS Behav. 2017;21:2526–32.CrossRef Chamberlain N, Mena LA, Geter A, Crosby RA. Is sex with older male partners associated with higher sexual risk behavior among young black MSM? AIDS Behav. 2017;21:2526–32.CrossRef
25.
go back to reference Khosropour CM, Dombrowski JC, Swanson F, Kerani RP, Katz DA, Barbee LA, et al. Trends in serosorting and the association with HIV/STI risk over time among men who have sex with men. J Acquir Immune Defic Syndr. 2016;72:189–97.CrossRef Khosropour CM, Dombrowski JC, Swanson F, Kerani RP, Katz DA, Barbee LA, et al. Trends in serosorting and the association with HIV/STI risk over time among men who have sex with men. J Acquir Immune Defic Syndr. 2016;72:189–97.CrossRef
26.
go back to reference Redoschi BRL, Zucchi EM, dos Santos Barros CR, Paiva VSF, Redoschi BRL, Zucchi EM, et al. Routine HIV testing in men who have sex with men: from risk to prevention. Cad Saúde Pública. 2017;33(4):e00014716.CrossRef Redoschi BRL, Zucchi EM, dos Santos Barros CR, Paiva VSF, Redoschi BRL, Zucchi EM, et al. Routine HIV testing in men who have sex with men: from risk to prevention. Cad Saúde Pública. 2017;33(4):e00014716.CrossRef
27.
go back to reference Hess KL, Crepaz N, Rose C, Purcell D, Paz-Bailey G. Trends in sexual behavior among men who have sex with men (MSM) in high-income countries, 1990–2013: a systematic review. AIDS Behav. 2017;21:2811–34.CrossRef Hess KL, Crepaz N, Rose C, Purcell D, Paz-Bailey G. Trends in sexual behavior among men who have sex with men (MSM) in high-income countries, 1990–2013: a systematic review. AIDS Behav. 2017;21:2811–34.CrossRef
28.
go back to reference Del Pino HE, Harawa NT, Liao D, Moore AA, Karlamangla AS. Age and age discordance associations with condomless sex among men who have sex with men. AIDS Behav. 2018;22:649–57.CrossRef Del Pino HE, Harawa NT, Liao D, Moore AA, Karlamangla AS. Age and age discordance associations with condomless sex among men who have sex with men. AIDS Behav. 2018;22:649–57.CrossRef
29.
go back to reference Banandur P, Rajaram SP, Mahagaonkar SB, Bradley J, Ramesh BM, Washington RG, et al. Heterogeneity of the HIV epidemic in the general population of Karnataka state, south India. BMC Public Health. 2011;11(Suppl 6):S13.CrossRef Banandur P, Rajaram SP, Mahagaonkar SB, Bradley J, Ramesh BM, Washington RG, et al. Heterogeneity of the HIV epidemic in the general population of Karnataka state, south India. BMC Public Health. 2011;11(Suppl 6):S13.CrossRef
Metadata
Title
Regional disparity of HIV incidence and prevalence among men who have sex with men
Authors
D. N. Vergara-Ortega
H. López-Gatell
S. Bautista-Arredondo
A. Colchero
S. G. Sosa-Rubí
M. Morales-Vazquez
A. Herrera-Ortiz
M. Olamendi-Portugal
S. García-Cisneros
E. E. Sevilla-Reyes
M. Hernández-Avila
M. A. Sánchez-Alemán
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06582-x

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.